Previous Article | Next Article ![]()
Journal of Virology, January 1999, p. 495-500, Vol. 73, No. 1
Fred Hutchinson Cancer Research Center,
Seattle, Washington 98109,1 and
Departments of Pathology,4
Pediatrics,2 and
Medicine,3 University of Washington,
Seattle, Washington 98195
Received 7 August 1998/Accepted 25 September 1998
Transduction by murine leukemia virus-based retrovirus vectors is
limited in certain cell types, particularly in nondividing cells. But
transduction can be inefficient even in cells that divide rapidly. For
example, exposure of 208F rat embryo fibroblasts to an excess of an
amphotropic retrovirus vector encoding alkaline phosphatase results in
a transduction efficiency of only about 10%, even though these cells
divide rapidly. Here we show that transduction of 208F cells is limited
by cell surface retrovirus receptor levels; overexpression of the
amphotropic retrovirus receptor Pit2 markedly improved the transduction
efficiency to 50%. To characterize receptor levels and binding
affinity, we synthesized a fusion protein that joins the amino terminus
of the amphotropic envelope protein to the Fc region of a human
immunoglobulin G1 molecule for use in binding assays. In comparison to
the parental cell line, the modified cell line showed an order of
magnitude increase in binding sites of from 18,000 to 150,000 per cell. Thus, efficient transduction by an amphotropic retrovirus vector requires high-level expression of the retrovirus receptor Pit2. These
results provide the rationale for further examination of the role of
receptor levels in inefficient transduction, especially with regard to
target cells for gene therapy, where a high transduction rate is often crucial.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Efficient Transduction by an Amphotropic Retrovirus
Vector Is Dependent on High-Level Expression of the Cell Surface
Virus Receptor
*
Corresponding author. Mailing address: Fred Hutchinson
Cancer Research Center, 1100 Fairview Ave. North, Room C2-023, Seattle, WA 98109-1024. Phone: (206) 667-2890. Fax: (206) 667-6523. E-mail: dmiller{at}fhcrc.org.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|